Grave's Disease
Grave's Disease is an autoimmune disorder that causes the thyroid gland to become overactive, leading to symptoms such as weight loss, rapid heartbeat, and anxiety.
Graves' Disease: IMVT-1402 Treatment Study
We are studying a new treatment called IMVT-1402 for adults with Graves' disease. The aim is to see if it can improve thyroid hormone levels compared to a placebo.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have a diagnosis of Graves' disease (GD)?
- Have you received any thyroid hormone treatments like levothyroxine or T3 in the last 6 weeks?
- Have you had any surgery to remove your thyroid or received radioactive iodine treatment before?
- Do you have any other autoimmune diseases that require treatment?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Imvt-1402
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Imelda
Endocrinology and Nephrology
Hever, Belgium
Hopital Erasme
Division of Endocrinology
Negenmanneke, Belgium
Az St-Jan Brugge-Oostende A.V.
Internal Medicine / Endocrinology
Sint-Andries, Belgium
Sponsor: Immunovant Sciences GmbH
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.